Abstract
Graft coronary arteriosclerosis, which limits the long-term survival of allograft recipients, is characterized by diffuse intimal thickening composed of proliferative smooth muscle cells1,2. We observed that messenger RNA of the cell cycle regulatory enzyme cyclin-dependent kinase (cdk) 2 kinase, which mediates smooth muscle cell proliferation, was elevated in the thickened intima of coronary arteries of murine heterotopic cardiac allo-grafts. We studied the effects of antisense phosphorothioate oligodeoxynucleotide (ODN) against this enzyme using gene transfer mediated by a hemagglutinating virus of Japan (HVJ)–liposome complex intraluminally delivered to inhibit the intimal hyperplasia. At 30 days after transplantation, antisense cdk2 kinase ODN treatment had dramatically inhibited neointi-mal formation in the allografts. Expression of vascular cell adhesion molecule-1 was also suppressed by antisense cdk2 kinase. However, these effects were not observed in the sense or scrambled ODN-treated allografts. Thus, an intraluminal administration of antisense ODN directed to a specific cell cycle regulatory gene can inhibit neointimal formation after cardiac transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hosenpud, J.D., Novick, R.J., Breen, T.J., Berkeley, K. & Daily, O.P. The registry of the international society for heart and lung transplantation: Twelfth official report, 1995. J. Heart Lung Transplant. 11, 805–815 (1995).
Botas, J. et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy: An intravascular ultrasound study. Circulation 92, 1126–1132 (1995).
Suzuki, J. et al. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts: A study in rat and monkey models. Circulation 94, 1118–1124 (1996).
Hosenpud, J.D. Immune mechanism of cardiac allograft vasculopathy: An update. Transplant. Immunology 1, 237–249 (1993).
Pollak, R. & Fabrega, A.J. Diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N. Engl. J. Med. 328, 1851–1852 (1993).
Larsen, C.P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434–438 (1996).
Furukawa, Y., Matsumori, A., Hirozane, T. & Sasayama, S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model: A comparative study with captopril. Circulation 93, 333–339 (1996).
Pagano, M., Draetta, G. & Durr, J. Association of cdk 2 kinase with the transcription factor E2F during S phase. Science 255, 1144–1147 (1992).
Tsai, L.H., Harlow, E. & Meyerson, M. Isolation of the human cdk2 gene that encodes the cycline A and adenovirus E1 A associated p33 kinase. Nature 353, 174–177 (1991).
Koff, A., Otsuki, M., Polyak, K., Roberts, J.M. & Massague, J. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta. Science 260, 536–539 (1993).
Morishita, R. et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 93, 1458–1464 (1994).
Morishita, R. et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90, 8474–8478 (1993).
Kaneda, Y., Iwai, K. & Uchida, T. Increased expression of DMA cointroduced with nuclear protein in adult rat liver. Science 243, 375–378 (1989).
Nuovo, G.J., Gallery, F., MacConnell, P. & Braun, A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144, 659–666 (1994).
Sawa, Y. et al. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJS liposome. Circulation 92 (Suppl. 2), 479–482 (1995).
Dzau, V.J., Mann, M.J., Morishita, R. & Kaneda, Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. USA 93, 11421–11425 (1996).
Isobe, M., Yagita, H., Okumura, K. & Ihara, A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255, 1125–1127 (1992).
Suzuki, J. et al. Inhibition of accelerated coronary atherosclerosis with short-term blockade of ICAM-1 and LFA-1 in the heterotopic murine model of cardiac transplantation. J. Heart Lung Transplant. (in the press).
Eich, D.M. et al. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87, 261–269 (1993).
Cybulsky, M.I. & Gimbrone, M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, JI., Isobe, M., Morishita, R. et al. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Nat Med 3, 900–903 (1997). https://doi.org/10.1038/nm0897-900
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0897-900
This article is cited by
-
Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy
Nature Protocols (2007)
-
Cardiac allograft vasculopathy: The achilles’ heel of long-term survival after cardiac transplantation
Current Atherosclerosis Reports (2006)
-
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice
Gene Therapy (2001)
-
Gene therapy in transplantation in the year 2000: moving towards clinical applications?
Gene Therapy (2000)
-
Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts
Gene Therapy (2000)